RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

Abstract Background Despite obvious advances over the last decades, locally advanced adenocarcinomas of the gastroesophageal junction (GEJ) still carry a dismal prognosis with overall 5-year survival rates of less than 50% even when using modern optimized treatment protocols such as perioperative ch...

Full description

Bibliographic Details
Main Authors: Sylvie Lorenzen, Alexander Biederstädt, Ulrich Ronellenfitsch, Christoph Reißfelder, Stefan Mönig, Frederik Wenz, Claudia Pauligk, Martin Walker, Salah-Eddin Al-Batran, Bernhard Haller, Ralf-Dieter Hofheinz
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
Locally advanced adenocarcinoma of the gastroesophageal junction
Neoadjuvant radiochemotherapy
Perioperative chemotherapy
FLOT
Online Access:http://link.springer.com/article/10.1186/s12885-020-07388-x

Internet

http://link.springer.com/article/10.1186/s12885-020-07388-x

Similar Items